JMAC Enterprises’s Eli Lilly LLY Stock Holding History

JMAC Enterprises’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,674	Closed	-$1.29M	–	141
2024 Q4	$1.29M	Sell	1,674 -12	-0.7%	-$9.94K	0.2%	89
2024 Q3	$1.49M	Buy	1,686 +48	+3%	+$43.2K	0.24%	85
2024 Q2	$1.48M	Buy	1,638 +9	+0.6%	+$7.2K	0.26%	83
2024 Q1	$1.27M	Sell	1,629 -197	-11%	-$140K	0.24%	84
2023 Q4	$1.06M	Buy	1,826 +237	+15%	+$138K	0.23%	87
2023 Q3	$854K	Buy	1,589 +9	+0.6%	+$4.64K	0.21%	89
2023 Q2	$741K	Hold	1,580	–	–	0.18%	98
2023 Q1	$543K	Hold	1,580	–	–	0.14%	111
2022 Q4	$578K	Hold	1,580	–	–	0.16%	109
2022 Q3	$511K	Hold	1,580	–	–	0.14%	123
2022 Q2	$512K	Hold	1,580	–	–	0.13%	124
2022 Q1	$452K	Hold	1,580	–	–	0.11%	131
2021 Q4	$379K	Buy	+1,580	New	+$401K	0.09%	134

Other funds holding LLY

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JMAC Enterprises's LLY Position: Q1 2025 in Review

JMAC Enterprises sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 1,674 shares — an estimated $1.29M sold.

JMAC Enterprises first reported a position in LLY in Q4 2021 and held it in 13 quarters. The position peaked at $1.49M in Q3 2024. 3,919 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

JMAC Enterprises reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
JMAC Enterprises sold 1,674 Eli Lilly shares in Q1 2025, an estimated $1.29M.
JMAC Enterprises first reported a position in Eli Lilly in Q4 2021 and held it in 13 quarters.
JMAC Enterprises's Eli Lilly position peaked at $1.49M in Q3 2024.
3,919 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on JMAC Enterprises's 13F filing for Q1 2025, filed 22 Apr 2025.